ScioScientific LLC

ScioScientific LLC Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from ScioScientific LLC, Morristown, NJ.

The ScioScientific team has a broad range of skills and experience in clinical and academic medicine, pharmaceutical and healthcare brand management, high-level strategy consulting, interactive media, project management, and event management.

The name Ozempic is becoming synonymous with “weight-loss drugs”, even though it’s technically a brand for diabetes trea...
11/03/2025

The name Ozempic is becoming synonymous with “weight-loss drugs”, even though it’s technically a brand for diabetes treatment. What happens when a brand turns into a generic term—and what does this mean for patients, regulation, and marketing? Read more on this.

What do Rollerblades and Ozempic have in common? Host Alex Hogan explains in the latest episode of STATus Report.

New research finds that an AI-powered lifestyle program produced nearly identical results to a human-led diabetes preven...
11/02/2025

New research finds that an AI-powered lifestyle program produced nearly identical results to a human-led diabetes prevention program, opening up new possibilities in how we fight prediabetes at scale. Here's more on this.

And, ahead of earnings readouts this week, some key, publicly-traded digital health companies announced leadership changes.

Health insurance costs are climbing — employer-sponsored family coverage premiums rose by 6% in 2025, reaching nearly $2...
11/01/2025

Health insurance costs are climbing — employer-sponsored family coverage premiums rose by 6% in 2025, reaching nearly $27,000 per year. The biggest drivers? Rising drug, hospital and chronic-care costs.

The cost of workplace health insurance rose faster than inflation or wages.

A new blood test from Signatera™ (by Natera) shows promise for cancer care by detecting minute traces of tumor DNA (ctDN...
10/31/2025

A new blood test from Signatera™ (by Natera) shows promise for cancer care by detecting minute traces of tumor DNA (ctDNA) — helping identify who may need extra treatment and who might safely do without. Here's more on this.

Data at ESMO 2025 bolstered the case that blood tests could help doctors sort which patients need additional therapy, and who can be spared.

Popular physician-creator Doctor Mike argues that medical organizations must step up their social media game to rebuild ...
10/30/2025

Popular physician-creator Doctor Mike argues that medical organizations must step up their social media game to rebuild trust and fight health misinformation. Here's more on this.

Trust in public health institutions has been declining for years. Popular YouTuber “Doctor Mike” has some ideas for how to fix that.

The last known Ebola virus disease patient in the latest outbreak in the Democratic Republic of the Congo has been disch...
10/29/2025

The last known Ebola virus disease patient in the latest outbreak in the Democratic Republic of the Congo has been discharged — no new cases have been reported since September 25. A 42-day countdown has begun to officially declare the outbreak over if no further cases emerge. Here's more on this.

The WHO announced that the last Ebola patient in Congo’s latest outbreak was discharged over the weekend and no new cases have been reported since Sept. 25.

A new multi-cancer blood test is showing promise — potentially detecting more cancer types earlier than standard screeni...
10/28/2025

A new multi-cancer blood test is showing promise — potentially detecting more cancer types earlier than standard screenings, but experts say it’s still too early to replace traditional diagnostics and further validation is needed. Here's more on this.

Grail announced fresh data on Friday from a large U.S. study of its flagship Galleri blood-based test for detecting dozens of tumor types.

Two cases of a rare strain of mpox, detected in California with no recent travel history, signal potential local spread,...
10/27/2025

Two cases of a rare strain of mpox, detected in California with no recent travel history, signal potential local spread, though officials stress the overall risk to the public remains low. Here's more on this.

Two California mpox cases are raising concerns, but health officials say the risk to the public remains low.

Former Massachusetts Representative Joe Kennedy III has publicly broken with his uncle, Robert F. Kennedy Jr. — citing “...
10/26/2025

Former Massachusetts Representative Joe Kennedy III has publicly broken with his uncle, Robert F. Kennedy Jr. — citing “grave concerns” about the safety and integrity of our U.S. health system and calling for his uncle’s resignation as HHS Secretary. Here's more on this.


Joe Kennedy III split with uncle RFK Jr. over 'grave concerns' about U.S. health, he said at

Innovation in drug development is at risk as recent turmoil at the Food and Drug Administration has thrown industry lead...
10/25/2025

Innovation in drug development is at risk as recent turmoil at the Food and Drug Administration has thrown industry leaders into uncertainty—companies like Replimune Group and Capricor Therapeutics, once poised for major approvals are now facing unexpected roadblocks. Read more on this.

The FDA's rejections of Replimune and Capricor therapies show how instability threatens biotech innovation, CEOs say.

Cutting funding now could stall the next wave of cancer immunotherapies. Research led by Dr. Miriam Merad at the Icahn S...
10/24/2025

Cutting funding now could stall the next wave of cancer immunotherapies. Research led by Dr. Miriam Merad at the Icahn School of Medicine at Mount Sinai shows just how close we are, but shrinking resources threaten the breakthroughs. Here's more on this.

"We're so close." Dr. Miriam Merad says NIH cuts could derail life-saving cancer research just as scientists close in on new immune cell–based therapies.

Amid the federal shutdown, the Centers for Medicare & Medicaid Services (CMS) initially said it would pause all Medicare...
10/23/2025

Amid the federal shutdown, the Centers for Medicare & Medicaid Services (CMS) initially said it would pause all Medicare payments to doctors — but has now scaled back the hold to only select claims tied to expired programs like telehealth and rural services. Payments for most services will continue as usual, but the shift highlights how fragile provider reimbursement can be when politics clash with healthcare. Read more on this.

The Centers for Medicare and Medicaid Services backed off a plan to pause Medicare payments to doctors amid the government shutdown.

Address

Morristown, NJ
07960

Telephone

+19739086566

Alerts

Be the first to know and let us send you an email when ScioScientific LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram